SCHEMBL8196676

SCHEMBL8196676

C=C(O)c1nc2ccc([N+](=O)[O-])cc2c(=O)[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
MEN1 O00255 2/20 0.54
POLB P06746 2/20 0.54
KMT2A Q03164 2/20 0.54
PLA2G1B P04054 1/20 0.54
DUSP3 P51452 1/20 0.54
CTDSP1 Q9GZU7 1/20 0.54
ATG4B Q9Y4P1 1/20 0.54
SAE1 Q9UBE0 1/20 0.54
UBA2 Q9UBT2 1/20 0.54
PARP1 P09874 3/20 0.52
CA12 O43570 2/20 0.48
CA9 Q16790 2/20 0.48
GUSB P08236 2/20 0.45
ALPI P09923 1/20 0.45
TNKS O95271 1/20 0.45
NLRP3 Q96P20 1/20 0.45
TNKS2 Q9H2K2 1/20 0.45
PARP2 Q9UGN5 1/20 0.45
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8201681 0.87 MEN1 (0.58) MAPTMEN1POLBKMT2APLA2G1B
SCHEMBL28738676 0.82 MAPT (0.59) MAPTMEN1POLBKMT2APLA2G1B
SCHEMBL29488257 0.80 MAPT (0.54) MAPTMEN1POLBKMT2APLA2G1B
SCHEMBL28738684 0.80 MAPT (0.54) MAPTMEN1POLBKMT2APLA2G1B
SCHEMBL2257236 0.80 PARP1 (0.57) MAPTMEN1POLBKMT2APARP1
SCHEMBL29839746 0.80 PARP1 (0.57) MAPTMEN1POLBKMT2APARP1
SCHEMBL28738671 0.79 MAPT (0.51) MAPTMEN1POLBKMT2APLA2G1B
SCHEMBL4936663 0.79 MAPT (0.51) MAPTMEN1POLBKMT2APLA2G1B
SCHEMBL28872357 0.78 PARP1 (0.56) MAPTMEN1POLBKMT2APLA2G1B
SCHEMBL3020634 0.78 PARP1 (0.56) MAPTMEN1POLBKMT2APLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008063668-A1 HETEROBICYCLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2008-05-29 WO disclosed